Early Alzheimer’s Disease Screening Approach Using Plasma Biomarkers

Early Alzheimer’s Disease Screening Approach Using Plasma Biomarkers

Alzheimer’s disease (AD) is the most prevalent dementia, but it shows similar initial symptoms to other neurocognitive diseases (Lewy body disease (LBD) and frontotemporal dementia (FTD)). Thus, the identification of reliable AD plasma biomarkers is required. The aim of this work is to evaluate the...

Full description

Bibliographic Details
Main Authors: Lourdes Álvarez-Sánchez, Carmen Peña-Bautista, Laura Ferré-González, Laura Cubas, Angel Balaguer, Bonaventura Casanova-Estruch, Miguel Baquero, Consuelo Cháfer-Pericás
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:International Journal of Molecular Sciences
Subjects:
Alzheimer’s disease
frontotemporal dementia
plasma
biomarker
SIMOA
diagnosis
Online Access:https://www.mdpi.com/1422-0067/24/18/14151

Internet

https://www.mdpi.com/1422-0067/24/18/14151

Similar Items